Related Experiment Video
Updated: Jan 22, 2026

FM Dye Cycling at the Synapse: Comparing High Potassium Depolarization, Electrical and Channelrhodopsin Stimulation
Published on: May 24, 2018
Cycling Stability of Layered Potassium Manganese Oxide in Nonaqueous Potassium Cells
Min Kyoung Cho1, Jae Hyeon Jo1, Ji Ung Choi1
1Department of Nanotechnology and Advanced Materials Engineering & Sejong Battery Institute , Sejong University , Seoul 05006 , South Korea.
Abstract:
Potassium-ion batteries have emerged as an alternative to lithium-ion batteries as energy storage systems. In particular, KMnO2 has attracted considerable attention as a cathode material because of its high theoretical capacity and low cost. In this study, partial substitution of Mn in P3-type K0.5MnO2 with divalent Ni is performed, resulting in a first discharge capacity of approximately 121 mAh (g-oxide)-1 with 82% retention for 100 cycles. Operando synchrotron X-ray diffraction analysis reveals the occurrence of phase transition from P3 to O3 on charge and O3-P3-P'3 transition on discharge at the first cycle, where P'3 is a new distorted form of the P3 phase, accompanied by reversible Mn4+/3+ and Ni3+/2+ redox pairs, as evidenced by X-ray absorption spectroscopy. The reduced variation in the lattice parameters during de/potassiation for P3-K0.5[Ni0.1Mn0.9]O2 relative to P3-K0.5MnO2 is suggested as a possible reason for the enhanced electrochemical performance of K0.5[Ni0.1Mn0.9]O2. These results open the possibility of using inexpensive and high-capacity Mn-based cathode active materials for potassium-ion batteries.
Related Concept Videos
Oxidation of Alkenes: Syn Dihydroxylation with Potassium Permanganate
Regulation of Sodium and Potassium
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
Roles of Electrolytes: Sodium and Potassium
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

